2 results match your criteria: "Hanzhong City People's Hospital[Affiliation]"
Therapeutic effect of captopril combined with phosphocreatine sodium on viral myocarditis.
Am J Transl Res
December 2022
Cardiology Department, Hanzhong City People's Hospital No. 251 North Tuanjie Street, Hanzhong 723000, Shaanxi, China.
Objective: To analyze the therapeutic effect of captopril combined with phosphocreatine sodium in patients with viral myocarditis.
Methods: A total of 140 patients with infectious myocarditis who received treatment in Hanzhong City People's Hospital from December 2019 to January 2022 were retrospectively enrolled as study subjects. 61 of them were treated with captopril and constituted the control group (CG), and the remaining 79 who received phosphocreatine sodium in addition to captopril were the research group (RG).
Serum TSGF and miR-214 levels in patients with hepatocellular carcinoma and their predictive value for the curative effect of transcatheter arterial chemoembolization.
Ann Palliat Med
July 2020
Department of Tumor Thoracic Surgery, Hanzhong City People's Hospital, Hanzhong, China.
Background: The purpose of this study is to evaluate the expression of tumor-specific growth factor (TSGF) and microRNA-214 (miR-214) in the serum of patients with primary hepatocellular carcinoma (PHC) and their predictive values for the curative effect of transcatheter arterial chemoembolization (TACE).
Methods: A retrospective analysis of the clinical data of 87 PHC patients were treated with TACE. According to the curative effect 1 month after TACE, PHC patients were divided into disease control group (n=56) and disease progression group (n=31).